Patients undergoing treatments in hospitals may develop some infections during their stay in the hospitals. These infections are known as hospital-acquired
infections (HAI) or hospital infections. These infections are most virulent in healthcare settings such as nursing homes, hospitals, rehabilitation
centers, outpatient surgery centers, and dialysis centers.
Hospital-acquired infections are induced by viral, bacterial, and fungal pathogens. It has been observed that more cases of HAIs emerge from ICUs
(Intensive Care Units) as against various other divisions. Awareness, improved sanitation, training, and infection control are the definite ways of
controlling and preventing HAIs.
Browse the full Global HAIs Control Market Report
The global hospital-acquired infections (HAI) control market was valued at US$50,807.0 million in 2014. It is expected to expand at a CAGR of 8.5% between
2014 and 2020, gradually attaining a total market value of US$82,889.4 million by 2020.
Major Market Trends:
The market for hospital-acquired infections (HAIs) control is categorized by diagnosis method, cleaning and sterilization techniques, treatments as well as
diseases, and geographical divisions. Gas plasma sterilization technology is gaining tremendous demand in the overall HAIs control market, since effective
sterilization is the most efficacious way of eliminating HAIs. STERIS Corporation is a key player for cleaning and sterilization products in the HAIs
control market, holding about 25% of the cleaning and sterilization market in the year 2013. Additionally, Getinge AB constitutes for approximately 24% in
the global cleaning and sterilization market for HAIs control.
Over the past three years, the key players dominating the global HAIs control market have maintained new product launches and developments, agreements,
collaborations, geographical expansions, and partnerships as their major business strategies to maintain their growth prospects in this market.
Browse the full Press Release of HAIs Control Market
North America is the Major Regional Market for HAIs Control
On the basis of geography, the global HAIs control market has been segmented into North America, Europe, Asia Pacific and Rest of the World (RoW). These
regions are further segmented into nations such as France, Germany, China, the U.K., Rest of Europe, and Rest of Asia. The overall HAIs control market is
dominated by North America. Rising demand for advanced drugs and rising amount of multidrug-resistant microbial pathogens are primarily the factors that
propel the North America HAIs control market. However, due to increase in income levels as well as improved healthcare infrastructure, it is the Asia
Pacific HAIs control market that will experience the highest growth rate during the forecast period from 2014 to 2020. The prime factor responsible for the
rapid growth of this market is increasing prevalence of hospital-acquired infections in the region and increasing purchasing power of the people, which
will add to the demand from the HAIs control market in this region.